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Introduction
Hereditary autoinflammatory diseases (AID) are charac-
terized by recurrent bouts of systemic inflammation
caused by dysregulation of the innate immunity system.
The genotype-phenotype correlation can be highly vari-
able which makes a genetic diagnosis in AID patients
complex and laborious. A clear and definitive diagnosis
cannot be provided for up to 80% of AID patients, which
can be important for treatment options. To date, over
20 causal genes have been identified for monogenic AIDs.
Patients and methods
We have developed a diagnostic method to facilitate
genetic evaluation of the 23 known AID related genes at
once using Next Generation Sequencing (NGS). We per-
formed targeted in-solution enrichment followed by
sequencing using the SOLID 5500 platform. An in-house
developed bioinformatic pipeline was used to detect DNA
variants in the selected AID genes. Cartagenia Bench lab
NGS was used for filtering and classifying detected var-
iants. Variants were confirmed by Sanger sequencing.
Since May 2013, 120 patients have been tested with NGS.
Results
We identified a genetic diagnosis in 17 patients (14%).
Mutations were detected in classic autoinflammatory
genes like MVK, NLRP3 and TNFRSF1A. Moreover, we
detected mutations in recently discovered genes, like
CECR1, thereby demonstrating that regular updating of
the targeted gene panel is warranted. Interestingly, we
detected mosaicism for a pathogenic NLRP3 mutation
which had been missed by Sanger sequencing. Moreover
in a patient with the phenotype of PAPA-syndrome, with-
out a mutation in the PSTPIP1-gene, pathogenic com-
pound heterozygous mutations in the MVK-gene were
detected with NGS. This further supports the application
of NGS based testing in these patients. In 20 additional
patients (17%) only one disease causing allele was detected
in genes involved in autosomal recessive disorders or the
genetic results need further testing because the detected
variants were of unknown clinical significance. The NGS
method has been mainly applied to autoinflammatory
patients other than FMF patients. In these patients diag-
nostic yield improved from 4% using Sanger sequencing
single genes to 14% using the NGS based testing.
Conclusions
Our results indicate that this NGS-based approach is an
efficient strategy for rapid mutation detection in AID.
Moreover, the increased diagnostic yield will give more
insight in the genotype phenotype relationship for the dif-
ferent AID disorders enabling earlier diagnosis and better
treatment.
Authors’ details
1University Medical Center Utrecht, Medical Genetics, Utrecht, Netherlands.
2University Medical Center Utrecht, Pediatric Immunology and Infectious
diseases, Utrecht, Netherlands. 3Radboud University Medical Center, Internal
Medicine (NCIA), Nijmegen, Netherlands.
Published: 28 September 2015
doi:10.1186/1546-0096-13-S1-P51
Cite this article as: Elferink et al.: Targeted NGS based hereditary
autoinflammatory disorder screening in routine diagnostics, two year
experience in the Netherlands. Pediatric Rheumatology 2015 13(Suppl 1):
P51.
1University Medical Center Utrecht, Medical Genetics, Utrecht, Netherlands
Full list of author information is available at the end of the article
Elferink et al. Pediatric Rheumatology 2015, 13(Suppl 1):P51
http://www.ped-rheum.com/content/13/S1/P51
© 2015 Elferink et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
